Outcomes of Ceftriaxone compared with Cefazolin OR Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive Staphylococcus aureus (MSSA) BSIs - Results from a Large United States Claims Database
โ Just Accepted
๐ https://t.co/T7H0MpuvK4
@igegeorgemd @washuid
ID community, for HIV patients with disseminated histoplasmosis and tuberculosis.
1) What azole do you recommend considering the strong DDI with itraconazole and rifampin/rifabutin?
2)Do you have any ART of preference if genotype is wild type?
Thanks
You're invited!
Would you like to learn about private practice ID - the MIDC model?
Come join @MIDCUSA during @IDWeek2022 on October 20, 2022 at 6:30 PM for dinner at RPM Italian.
Limited to physicians only, no guests please. RSVP ๐
https://t.co/GkuVRTq554
#IDtwitter
@utmb_ID Would check cefedericol to see if that is still an option. Would consider ceftazidime/avibactam plus Aztreonam. I would also consider high dose amp/sulb plus tige plus something for the pan-sensitive pseudomonas.
@Pranavi_MD was my first attending in the US back in 2013 when I was a med student. Today, I could have been her last ID fellow. Life is circle. Wish you the best ๐ช๐ป@UTSWInfDis
JOIN US: We're live now with UT Southwestern President Daniel Podolsky, M.D. and infectious diseases expert @DrJulieTMD for a COVID-19 community briefing. https://t.co/NpSvMMHDXt